1. Home
  2. BRTX vs HCTI Comparison

BRTX vs HCTI Comparison

Compare BRTX & HCTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRTX
  • HCTI
  • Stock Information
  • Founded
  • BRTX 1997
  • HCTI 2020
  • Country
  • BRTX United States
  • HCTI United States
  • Employees
  • BRTX N/A
  • HCTI N/A
  • Industry
  • BRTX Managed Health Care
  • HCTI Retail: Computer Software & Peripheral Equipment
  • Sector
  • BRTX Health Care
  • HCTI Technology
  • Exchange
  • BRTX Nasdaq
  • HCTI Nasdaq
  • Market Cap
  • BRTX 12.8M
  • HCTI 13.5M
  • IPO Year
  • BRTX N/A
  • HCTI 2021
  • Fundamental
  • Price
  • BRTX $1.54
  • HCTI $2.80
  • Analyst Decision
  • BRTX
  • HCTI
  • Analyst Count
  • BRTX 0
  • HCTI 0
  • Target Price
  • BRTX N/A
  • HCTI N/A
  • AVG Volume (30 Days)
  • BRTX 331.3K
  • HCTI 902.6K
  • Earning Date
  • BRTX 11-13-2025
  • HCTI 11-14-2025
  • Dividend Yield
  • BRTX N/A
  • HCTI N/A
  • EPS Growth
  • BRTX N/A
  • HCTI N/A
  • EPS
  • BRTX N/A
  • HCTI N/A
  • Revenue
  • BRTX $605,200.00
  • HCTI $11,866,000.00
  • Revenue This Year
  • BRTX $232.67
  • HCTI N/A
  • Revenue Next Year
  • BRTX $52.92
  • HCTI N/A
  • P/E Ratio
  • BRTX N/A
  • HCTI N/A
  • Revenue Growth
  • BRTX 247.62
  • HCTI N/A
  • 52 Week Low
  • BRTX $1.19
  • HCTI $1.37
  • 52 Week High
  • BRTX $2.55
  • HCTI $435.75
  • Technical
  • Relative Strength Index (RSI)
  • BRTX 47.02
  • HCTI 51.63
  • Support Level
  • BRTX $1.49
  • HCTI $2.61
  • Resistance Level
  • BRTX $1.70
  • HCTI $3.14
  • Average True Range (ATR)
  • BRTX 0.09
  • HCTI 0.19
  • MACD
  • BRTX -0.01
  • HCTI 0.00
  • Stochastic Oscillator
  • BRTX 33.33
  • HCTI 45.16

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

About HCTI Healthcare Triangle Inc.

Healthcare Triangle Inc is a healthcare information technology company focused on advancing industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the healthcare and life sciences industry. The company reinforces healthcare progress through technology and extensive industry know-how. HTI supports healthcare providers and payors, hospitals, and Pharma Life Sciences organizations in their effort to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business agility, and accelerated response to immediate business needs and competitive threats. It provides services under three operating segments: Software Services, Managed Services, and Support and Platform Services.

Share on Social Networks: